61 related articles for article (PubMed ID: 1725637)
1. [Hepatitis C virus antibodies in patients following blood transfusion and kidney transplantation].
Baur P; Daniel V; Pomer S; Scheurlen H; Opelz G; Roelcke D
Beitr Infusionsther; 1991; 28():27-8. PubMed ID: 1725637
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of antibody to hepatitis C virus in blood donors, high-risk groups and patients with liver diseases in Hungary. A multicentre study using ABBOTT EIA test and a comparison with an ORTHO ELISA test system.
Pár A; Kántor I; Barcsay E; Hollós I; Mezey I; Brojnás J; Takács M; Héjjas M; Illés M; Szontágh L
Acta Med Hung; 1991; 48(3-4):167-76. PubMed ID: 1726611
[TBL] [Abstract][Full Text] [Related]
3. [Decreasing the risk of post-transfusion non-A, non-B hepatitis by anti-HCV screening].
Holzberger G; Seidl S; Peschke B; Scheuermann EH; Schoeppe W
Beitr Infusionsther; 1992; 30():46-8. PubMed ID: 1284760
[TBL] [Abstract][Full Text] [Related]
4. [Hepatitis C virus antibodies (anti-HCV) prevalence rate in anti-HBc-negative blood donors].
Baur P; Roelcke D
Beitr Infusionsther; 1991; 28():25-6. PubMed ID: 1725631
[TBL] [Abstract][Full Text] [Related]
5. Low prevalence of anti-hepatitis C virus antibodies in female hemodialysis patients without blood transfusion: a multicenter analysis.
Nakayama E; Liu JH; Akiba T; Marumo F; Sato C
J Med Virol; 1996 Mar; 48(3):284-8. PubMed ID: 8801291
[TBL] [Abstract][Full Text] [Related]
6. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR
Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to hepatitis C virus: a cross-sectional study in patients attending a trauma unit or admitted to hospital for elective surgery.
García-Bengoechea M; Emparanza JI; Sarriugarte A; Cortés A; Vega JL; González F; Arenas JI
Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):237-41. PubMed ID: 7538032
[TBL] [Abstract][Full Text] [Related]
8. [Hepatitis C virus (HCV) antibodies in German blood donors--a pilot study].
Seidl S; Kühnl P; Beyer J; Stangel W; Flik J; Sibrowski W; Roos D; Bornhövd K; Kalmar G; Flacke H
Beitr Infusionsther; 1990; 26():18-21. PubMed ID: 2177676
[TBL] [Abstract][Full Text] [Related]
9. Extrahepatic immunological manifestations of hepatitis C virus in dialysis patients.
Canavese C; Hollò Z; Ciccone G; Ghisetti V; Barbui A; Fop F; Martina G; Forgnone F; Novo P; Thea A; Grill A; Marchiaro G
J Nephrol; 2000; 13(5):352-9. PubMed ID: 11063139
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of hepatitis B virus markers for surrogate testing of hepatitis C].
Ohto H; Nomura H; Ohmura K; Ishijima A; Okazaki S
Rinsho Byori; 1991 Jan; 39(1):14-7. PubMed ID: 1848910
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus (HCV) infection in haemodialysed patients: HCV-RNA and anti-HCV antibodies (third-generation assays).
Couroucé AM; Bouchardeau F; Chauveau P; Le Marrec N; Girault A; Zins B; Naret C; Poignet JL
Nephrol Dial Transplant; 1995; 10(2):234-9. PubMed ID: 7538650
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of antibodies to hepatitis C virus in patients on peritoneal dialysis--a multicenter study.
Gladziwa U; Schlipköter U; Lorbeer B; Cholmakow K; Roggendorf M; Sieberth HG
Clin Nephrol; 1993 Jul; 40(1):46-52. PubMed ID: 7689431
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of hepatitis C virus infection in children admitted to an urban hospital.
Gerner P; Wirth S; Wintermeyer P; Walz A; Jenke A
J Infect; 2006 Apr; 52(4):305-8. PubMed ID: 16473408
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C-virus (HCV) antibodies in patients after kidney transplantation.
Baur P; Daniel V; Pomer S; Scheurlen H; Opelz G; Roelcke D
Ann Hematol; 1991; 62(2-3):68-73. PubMed ID: 1851645
[TBL] [Abstract][Full Text] [Related]
15. [Prevalence of hepatitis A, B, C virus markers in Réunion (south hospital and Saint Pierre prison)].
Michault A; Faulques B; Sevadjan B; Troalen D; Marais A; Barau G
Bull Soc Pathol Exot; 2000 Feb; 93(1):34-40. PubMed ID: 10774493
[TBL] [Abstract][Full Text] [Related]
16. Estimated risk of transmission of hepatitis C virus by blood transfusion.
Koerner K; Cardoso M; Dengler T; Kerowgan M; Kubanek B
Vox Sang; 1998; 74(4):213-6. PubMed ID: 9691400
[TBL] [Abstract][Full Text] [Related]
17. [Hepatitis C antibodies in children and adolescents with congenital blood coagulation disorders].
Zenz W; Hofmann H; Muntean W
Wien Klin Wochenschr; 1991; 103(3):69-72. PubMed ID: 1851352
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to hepatitis C virus (HCV) in chronic renal failure (CRF) patients on conservative therapy: prevalence, risk factors and relationship to liver disease.
Fabrizi F; Marcelli D; Bacchini G; Guarnori I; Erba G; Locatelli F
Nephrol Dial Transplant; 1994; 9(7):780-4. PubMed ID: 7526275
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of hepatitis C in health care workers investigated by 2nd generation enzyme-linked and line immunoassays.
Frider B; Sookoian S; Castaño G; Rébora N; Gutfraind Z; Mirta K; Veyretou F; Wainstein C
Acta Gastroenterol Latinoam; 1994; 24(2):71-5. PubMed ID: 7817696
[TBL] [Abstract][Full Text] [Related]
20. [Liver impairment in kidney transplant recipients. 1. Prevalence and clinical significance of hepatitis C].
Ihara H; Kubo M; Miyamoto I; Nojima M; Koike H; Yabumoto H; Arima M; Ikoma F; Hiraoka K; Inagaki O
Nihon Jinzo Gakkai Shi; 1993 Oct; 35(10):1181-8. PubMed ID: 7505346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]